Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

Correo Farmaceutico – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

EU pharmaceutical legislation must support a competitive off-patent industry to deliver equitable access to medicines

Strong support for new measures to protect patient access to medicines in Northern Ireland

Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health

Commission study highlights market framework conditions are main driver for medicines shortages

New reports address generics pricing, innovation in the EU

Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries

European Parliament report calls for increased use of off-patent medicines to improve patient access

The EU must stop the offshoring of essential medicines manufacturing investments